Your session is about to expire
← Back to Search
tDCS for Post-Stroke Motor Impairment
Study Summary
This trial will test whether two different types of electrical brain stimulation can help people with motor impairments after a stroke.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have muscle and movement issues in my limb that was not paralyzed.My affected arm is very weak or has severe muscle loss.I do not have severe mental health issues that affect my understanding or communication.You have a pacemaker.I understand the details of the clinical trial and can consent to participate.I have significant weakness in one arm.I do not have severe health issues like heart or lung problems.I have metal implants in my head.You have had bad reactions to TMS and tDCS treatments in the past.
- Group 1: Cathodal stimulation
- Group 2: Anodal stimulation
- Group 3: Bilateral Stimulation
- Group 4: Sham stimulation
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could I potentially be included in this research endeavor?
"This clinical trial is recruiting 30 participants aged 18-90 who have experienced a stroke. To be eligible, they must demonstrate unilateral paresis with significant motor impairment of the affected upper limb and sign consent forms expressing their understanding of the study protocol."
How many participants have been selected to participate in this trial?
"Yes, the online information from clinicaltrials.gov confirms that this experiment is still in search of participants. Initially posted on September 30th 2022 and edited most recently on October 11th 2022, it requires 30 enrollees at a single site."
Is this study open to enrolment?
"According to clinicaltrials.gov, this research is actively enrolling participants; the trial was publicly published on September 30th 2022 and last modified eleven days later."
Is this research study accommodating participants aged above 35?
"This medical trial stipulates that participants must be aged 18 or above, with the maximum age eligibility being 90 years of age."
Share this study with friends
Copy Link
Messenger